Dezhen Technology Completes Series A Funding Round Led by Qiming Venture Partners

VCBeat has learned that Dezhen (Shanghai) Information Technology Co., Ltd. (“Dezhen Tech”) announced the completion of its Series A financing round, exclusively invested by Qiming Venture Partners, with Yuan Yi Capital serving as the exclusive long-term financial advisor. The funds will be primarily used for the research and development of smart healthcare products, helping large hospitals achieve digital transformation with next-generation cloud-native architecture.

Dezhen Technology is a technology company dedicated to the research and development of digital healthcare systems. With core products including integrated electronic medical records (EMR), next-generation hospital information systems (HIS), medical big data platforms, refined hospital operational management solutions, and regional healthcare information platforms, it builds a new digital ecosystem for smart hospitals.

To date, Dezhen Technology has established close partnerships with four of the top 10 hospitals on the Fudan University Hospital Rankings: Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Zhongshan Hospital affiliated with Fudan University, Huashan Hospital affiliated with Fudan University, and The First Affiliated Hospital of Sun Yat-sen University. The company has undertaken the development of next-generation core electronic medical record (EMR) systems for these leading hospital clients, receiving positive user feedback and achieving favorable results in EMR application level assessments.

Core technologies and the identification of genuine needs are key to Dezhen Technology gaining a first-mover advantage in industry upgrades.In terms of core technologies, Dezhen Technology’s new-generation core information system is built on cloud-native, microservices, and middle-platform architectures. Its entire product portfolio complies with “Xinchuang” (information technology application innovation) requirements, enabling more refined and intelligent clinical operations and enhancing service efficiency. Beyond infrastructure development, Dezhen has leveraged clinical knowledge and experience from leading hospitals to identify common clinical needs in real-world healthcare settings, and has developed a series of standardized products for specialty clinical management, translation of scientific research achievements, and hospital operational management.

The team’s integration of robust technical capabilities, extensive project experience, and strategic business insights is also a key reason why Dezhen Technology has gained recognition from large hospitals.Dezhen Technology is a technology R&D enterprise, with 85% of its staff being technical professionals. Its core technical team originates from the Microsoft Healthcare team and possesses an average of over 10 years of experience in managing healthcare IT projects. Over the past decade, this team has successfully helped nearly half of Shanghai’s tertiary public hospitals achieve IT restructuring.

Zhao Fei, Founder and Chairman of Dezhen TechnologyWith nearly 20 years of experience in the research and development, consulting, and project management of healthcare information technology, Zhao Fei has led Microsoft teams to deliver platform-based projects for more than half of Shanghai’s tertiary hospitals. Drawing on his extensive industry experience, Zhao Fei stated, “China’s healthcare institutions are currently undergoing an accelerated phase of digital transformation. Advances in medical technology, the accumulation of clinical expertise, the pursuit of high-standard hospital operations, and breakthroughs in artificial intelligence have all raised the bar for digital transformation in healthcare. We are delighted to collaborate with China’s leading large-scale hospitals in this digital journey, continuously enhancing our medical expertise and digital capabilities to provide digital transformation services to healthcare institutions across the country.”

Regarding this financing round, Zhao Fei stated, “First and foremost, we extend our sincere gratitude to Qiming Venture Partners for their trust and support in Dezhen Technology. This financing represents a milestone in the company’s development. Dezhen Technology will closely align with national healthcare reform policies, strive to expand market reach, meticulously refine our products, deliver exceptional customer service, and strengthen our innovation capabilities.”

Hu Xubo, Managing Partner at Qiming Venture Partnersstated, “The medical capabilities of large healthcare institutions in China have consistently kept pace with global leading standards, and even taken the lead in certain areas. The digital transformation of healthcare institutions will support the enhancement of both their clinical capabilities and operational efficiency. Recent technological advancements, including cloud-native architecture and artificial intelligence, will significantly reshape the product and service models of healthcare digitalization. We believe that Dezhen Technology’s team is deeply committed to the long-term development of healthcare and its digital transformation, with a strong focus on product and service capabilities, and is poised to play an even greater role in advancing healthcare digitalization. Qiming Venture Partners is pleased to have exclusively invested in Dezhen Technology and to participate in the journey of healthcare’s digital transformation.”

Yuan Yi CapitalSole long-term financial advisor for this financing transaction. Yuanyi Capital stated that, as a boutique investment bank focused on the healthcare and life sciences sector, it has long monitored the paradigm-shifting opportunities presented by new digital infrastructure. Leveraging next-generation microservices architecture, Dezhen Technology addresses the tripartite reform needs in medical quality, service, and management. It provides tiered support to leading hospitals as well as local and regional medical institutions in deploying digital information system platforms and achieving their smart hospital planning objectives. Yuanyi Capital looks forward to Dezhen Technology’s steady and rapid growth with the support of all parties, contributing to the industry’s intelligent and digital transformation.

Qiming Venture Partners was established in 2006 and has successively set up offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston, and the San Francisco Bay Area. Currently, Qiming Venture Partners manages 11 U.S. dollar funds and 7 RMB funds, with total assets under management reaching $9.4 billion. Since its inception, the firm has focused on investing in outstanding early-stage and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.

To date, Qiming Venture Partners has invested in more than 480 high-growth innovative companies, of which over 180 have achieved exits through listings on exchanges such as the New York Stock Exchange (NYSE), NASDAQ, Hong Kong Stock Exchange (HKEX), Shanghai Stock Exchange (SSE), and Shenzhen Stock Exchange (SZSE), as well as through mergers and acquisitions. More than 70 of these portfolio companies have become industry-recognized unicorns and super unicorns.